HealthUS FDA approves Takeda’s oral drug for narcolepsy
The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals’ oral drug for narcolepsy. The health regulator said the treatment is the first to target all symptoms of the rare sleep disorder. The decision gives people with narcolepsy a new oral treatment option.
R
Reuters★★★☆☆2026-08-05 23:30Original
US FDA approves Takeda’s oral drug for narcolepsy
Health